www.benzinga.com Open in urlscan Pro
151.101.2.137  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Would you like to be notified of the latest news and updates on the stock
market?

You can disable these notifications through your browser settings.

DenyAllow



NEW: UNLOCK HIGH-YIELD INVESTMENTS, CURATED BY EXPERTS



Get Access Now


 * Get Benzinga Pro
 * Data & APIs
 * Events
 * Premarket
 * Boost
 * Advertise

Contribute
España
India
Italia
대한민국
日本
LoginRegister
 * Our Services
 * News
   Earnings
   Guidance
   Dividends
   M&A
   Buybacks
   Legal
   Interviews
   Management
   Offerings
   IPOs
   Insider Trades
   Biotech/FDA
   Politics
   Healthcare
 * Markets
   Pre-Market
   After Hours
   Movers
   ETFs
   Forex
   Cannabis
   Commodities
   Binary Options
   Bonds
   Futures
   CME Group
   Global Economics
   Mining
   Previews
   Small-Cap
   Real Estate
   Penny Stocks
   Digital Securities
   Volatility
 * Options
 * Ratings
   Analyst Color
   Downgrades
   Upgrades
   Initiations
   Price Target
 * Ideas
   Trade Ideas
   Long Ideas
   Short Ideas
   Technicals
   From The Press
   Jim Cramer
   Rumors
   Whisper Index
   Stock of the Day
   Best Stocks & ETFs
   Best Penny Stocks
   Best S&P 500 ETFs
   Best Swing Trade Stocks
   Best Blue Chip Stocks
   Best High-Volume Penny Stocks
   Best Small Cap ETFs
   Best Stocks to Day Trade
   Best REITs
 * Money
   Investing
   Cryptocurrency
   Mortgage
   Insurance
   Yield
   Personal Finance
   Forex
   Startup Investing
   Real Estate Investing
   Prop Trading
   Credit Cards
   Stock Brokers
 * Crypto
 * Cannabis
   Cannabis Conference
   Earnings
   Interviews
   Deals
   Regulations
   Psychedelics


Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics

Research

My Stocks

Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
RecentMarkets

SPY

606.000.28%

QQQ

537.200.26%

BTC/USD

104988.700.9727%

DIA

437.140.36%

GLD

244.010.03%

TLT

89.960.75%


COMMENTS


Close menu
Loading...



TC BIOPHARM (HOLDINGS)

TCBPNASDAQ

Watchlist

Leave a Comment
Logo brought to you by Benzinga Data

Get Report
PerksBuyCompare Brokers
Get Report
PerksBuyCompare Brokers
$1.16

0.69147.33%
Pre-Market: 8:13 AM EDT
15 minutes delayed

Why is it moving?
TC BioPharm shares are trading higher after the company's Board approved a
special dividend.
Get Report

Comment


TC BioPharm (Holdings) (TCBP) ForecastNewsEarningsTC BioPharm (Holdings) (TCBP)
OptionsGuidanceDividends


ANALYST RATINGS

Insider TradesShort Interest

Consensus Rating1
Buy
Highest Price Target1
$5.00
Lowest Price Target1
$3.00
Consensus Price Target1
$4.00


TC BIOPHARM (HOLDINGS) (NASDAQ:TCBP) STOCK, ANALYST RATINGS, PRICE TARGETS,
FORECASTS

TC BioPharm (Holdings) PLC has a consensus price target of $4 based on the
ratings of 2 analysts. The high is $5 issued by EF Hutton on March 28, 2022. The
low is $3 issued by HC Wainwright & Co. on December 6, 2024. The 3 most-recent
analyst ratings were released by HC Wainwright & Co. on December 6, 2024, April
27, 2023, and January 26, 2023, respectively. With an average price target of
$6.33 between HC Wainwright & Co., there's an implied 445.98% upside for TC
BioPharm (Holdings) PLC from these most-recent analyst ratings.



ANALYST TRENDS AND FORECAST

1



Dec
Buy
Hold
Sell
Strong Sell

ANALYST RATING AND FORECAST


12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

ANALYST FIRMS MAKING RECOMMENDATIONS1

HC Wainwright & Co.
EF Hutton

1calculated from analyst ratings


ANALYST RATINGS FOR TC BIOPHARM (HOLDINGS)

All Ratings (4)Upgrades (0)Downgrades (0)Initiations (2)


date
▲▼
Buy NowUpside/Downside
▲▼
Analyst Firm
▲▼
Price Target Change
▲▼
Rating Change
▲▼
Previous / Current Rating
▲▼
Get Alert12/06/2024Buy Now158.62%HC Wainwright & Co.$7 → $3MaintainsBuyGet
Alert04/27/2023Buy Now503.45%HC Wainwright & Co.$18000 → $14000MaintainsBuyGet
Alert01/26/2023Buy Now675.86%HC Wainwright & Co. → $18000Initiates → BuyGet
Alert03/28/2022Buy Now331.03%EF Hutton → $500000Initiates → BuyGet Alert




ANALYST CALENDAR

Join Benzinga Edge and unlock all the major upgrades, downgrades, and changes to
the market's most accurate analysts.


Click to Join


Subscriber-Only Feature
UNLOCK EXPERT STOCK RATINGS
Discover Your
Next Winning Trade
Save 65% when you join today for less than $7 a month
members receive
 * Expert ratings on 1000+ stocks
 * Price target changes in real-time
 * Instant alerts on major upgrades and downgrades
 * Easy access to the best-performing analysts
 * Can't miss trend changes
 * Plus, more premium content, reports & tools

unlock access now


FAQ

Q


WHAT IS THE TARGET PRICE FOR TC BIOPHARM (HOLDINGS) (TCBP) STOCK?

A

The latest price target for TC BioPharm (Holdings) (NASDAQ:TCBP) was reported by
HC Wainwright & Co. on December 6, 2024. The analyst firm set a price target for
$3.00 expecting TCBP to rise to within 12 months (a possible 158.62% upside). 1
analyst firms have reported ratings in the last year.

Q


WHAT IS THE MOST RECENT ANALYST RATING FOR TC BIOPHARM (HOLDINGS) (TCBP)?

A

The latest analyst rating for TC BioPharm (Holdings) (NASDAQ:TCBP) was provided
by HC Wainwright & Co., and TC BioPharm (Holdings) maintained their buy rating.

Q


WHEN WAS THE LAST UPGRADE FOR TC BIOPHARM (HOLDINGS) (TCBP)?

A

There is no last upgrade for TC BioPharm (Holdings)

Q


WHEN WAS THE LAST DOWNGRADE FOR TC BIOPHARM (HOLDINGS) (TCBP)?

A

There is no last downgrade for TC BioPharm (Holdings).

Q


WHEN IS THE NEXT ANALYST RATING GOING TO BE POSTED OR UPDATED FOR TC BIOPHARM
(HOLDINGS) (TCBP)?

A

Analysts arrive at stock ratings after doing extensive research, which includes
going through public financial statements, talking to executives and customers
of TC BioPharm (Holdings), and listening in to earnings conference calls. Most
analysts do this every three months, so you should get 4 ratings per company per
firm each year. The last rating for TC BioPharm (Holdings) was filed on December
6, 2024 so you should expect the next rating to be made available sometime
around December 6, 2025.

Q


IS THE ANALYST RATING TC BIOPHARM (HOLDINGS) (TCBP) CORRECT?

A

While ratings are subjective and will change, the latest TC BioPharm (Holdings)
(TCBP) rating was a maintained with a price target of $7.00 to $3.00. The
current price TC BioPharm (Holdings) (TCBP) is trading at is $1.16, which is out
of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.


PEOPLE ALSO WATCH

Tharimmune Inc
NASDAQ:THAR
$2.23
2.23%

Synaptogenix Inc
NASDAQ:SNPX
$2.71
0.00%

Palisade Bio Inc
NASDAQ:PALI
$1.82
-4.40%

TransCode Therapeutics Inc
NASDAQ:RNAZ
$4.98
-26.81%

Protagenic Therapeutics Inc
NASDAQ:PTIX
$0.66
14.52%

Alaunos Therapeutics Inc
NASDAQ:TCRT
$1.93
-7.24%

TOVX





Show all 26 related companies


POPULAR CHANNELS

 * PreMarket Prep
 * Press Releases
 * Analyst Ratings
 * News
 * Options
 * ETFs


TOOLS & FEATURES

 * Real Time Feed
 * Public RSS Feeds
 * Submit News Tips
 * Blog
 * Embeddable Finance Widgets & Tools
 * Benzinga Catalyst


PARTNERS & CONTRIBUTORS

 * Affiliate Program
 * Contributor Portal
 * Licensing & Syndication
 * Sponsored Content
 * Advertise With Us
 * Lead Generation & SEO


ABOUT BENZINGA

 * About Us
 * Careers
 * In The News
 * Events
 * Contact Us

 * Terms & Conditions
 * Do Not Sell My Personal Data/Privacy Policy
 * Disclaimer
 * Service Status
 * Sitemap

© 2024 Benzinga | All Rights Reserved





word word word word word word word word word word word word word word word word
word word word word word word word word word word word word word word word word
word word word word word word word word word word word word word word word word
word word word word word word word word word word word word word word word word
word word word word word word word word word word word word word word word word
word word word word word word word word word word word word word word word word
word word word word word word word word word word word word word word word word
word word word word word word word word word word word word word word word word
word word word word word word word word word word word word word word word word
word word word word word word word word word word word word word word word word
word word word word word word word word word word word word word word word word
word word word word word word word word word word word word word word word word
word word word word word word word word

mmMwWLliI0fiflO&1
mmMwWLliI0fiflO&1
mmMwWLliI0fiflO&1
mmMwWLliI0fiflO&1
mmMwWLliI0fiflO&1
mmMwWLliI0fiflO&1
mmMwWLliI0fiflO&1
✕
Do not sell or share my personal information.
You have chosen to opt-out of the sale or sharing of your information from this
site and any of its affiliates. To opt back in please click the "Customize my ad
experience" link.

This site collects information through the use of cookies and other tracking
tools. Cookies and these tools do not contain any information that personally
identifies a user, but personal information that would be stored about you may
be linked to the information stored in and obtained from them. This information
would be used and shared for Analytics, Ad Serving, Interest Based Advertising,
among other purposes.

For more information please visit this site's Privacy Policy.
CANCEL
CONTINUE
Information from your device can be used to personalize your ad experience.

Do not sell or share my personal information.